Kevin L. Stark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kevin L. Stark has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Chris R. Kintner
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publicationGisele A. Deblandre
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publicationJan Kitajewski
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publicationJohn R. Shutter
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publicationSheila Scully
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publicationWei Fan
Departments of Molecular Genetics, 2Pathology, and 3Neurobiology, Amgen, Inc., Thousand Oaks, California 91320 USA; 4Department of Pathology and OB/GYN, Columbia University, College of Physicians and Surgeons, New York, New York 10032 USA; 5Molecular Neurobiology Laboratory, The SALK Institute for Biological Studies, La Jolla, California 90037 USA
1 shared publication
Latest Publications
- Open Access
- 1 June 2000
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 14 (11) , 1313-1318
Dll4, a novel Notch ligand expressed in arterial endothelium
We report the cloning and characterization of a new member of the Delta family of Notch ligands, which we have named Dll4. Like other Delta genes, Dll4 is predicted to encode a membrane-bound ligand, characterized by an extracellular region containing several EGF-like domains and a DSL domain required for receptor binding. In situ analysis reveals a highly selective expression pattern of Dll4 within the vascular endothelium. The activity and expression of Dll4 and the known actions of other members of this family suggest a role for Dll4 in the control of endothelial cell biology.
- 1 June 2000
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 14 (11) , 1313-1318
Open AccessDll4, a novel Notch ligand expressed in arterial endothelium
We report the cloning and characterization of a new member of the Delta family of Notch ligands, which we have named Dll4. Like other Delta genes, Dll4 is predicted to encode a membrane-bound ligand, characterized by an extracellular region containing several EGF-like domains and a DSL domain required for receptor binding. In situ analysis reveals a highly selective expression pattern of Dll4 within the vascular endothelium. The activity and expression of Dll4 and the known actions of other members of this family suggest a role for Dll4 in the control of endothelial cell biology.
- 1 June 1998
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 7 (6) , 859-864
Agrp, a novel gene implicated in the control of feeding
Rapid progress has recently been made to characterise a new pathway involved in the control of feeding behaviour, referred to as the melanocortinergic pathway. Studies of the obese phenotype of the yellow mouse mutant (Ay) suggested the existence of this feeding circuit for some time, but the precise molecular and biochemical regulation was unclear. Through pharmacological and genetic approaches, specific melanocortin receptors expressed within the brain are now known to play a pivotal role. Since receptor agonists decrease food intake, and blocking receptor activity (through antagonists or mutations) increases food intake, this pathway is thought to provide a tonic inhibitory effect on food consumption. A unique feature of this pathway seems to be the regulation of receptor activity by an endogenous protein antagonist, agouti-related protein (AGRP). The molecular characterisation and biochemical activity of this gene suggest that it plays a role in the regulation of feeding behaviour.
- 1 June 1998
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 7 (6) , 859-864
Agrp, a novel gene implicated in the control of feeding
Rapid progress has recently been made to characterise a new pathway involved in the control of feeding behaviour, referred to as the melanocortinergic pathway. Studies of the obese phenotype of the yellow mouse mutant (Ay) suggested the existence of this feeding circuit for some time, but the precise molecular and biochemical regulation was unclear. Through pharmacological and genetic approaches, specific melanocortin receptors expressed within the brain are now known to play a pivotal role. Since receptor agonists decrease food intake, and blocking receptor activity (through antagonists or mutations) increases food intake, this pathway is thought to provide a tonic inhibitory effect on food consumption. A unique feature of this pathway seems to be the regulation of receptor activity by an endogenous protein antagonist, agouti-related protein (AGRP). The molecular characterisation and biochemical activity of this gene suggest that it plays a role in the regulation of feeding behaviour.